TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events
5/17/2013 8:53:51 AM
More...
|
TNI BioTech Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
4/30/2013 6:35:01 AM
More...
|
TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
4/25/2013 11:29:08 AM
More...
|
TNI BioTech Files Form 10 With SEC
4/23/2013 9:09:23 AM
More...
|
TNI BioTech Acquires Exclusive License to the Portfilio of Patents of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From the Penn State Research Foundation
2/1/2013 9:56:34 AM
More...
|
TNI BioTech Announces Appointment of New CFO
1/22/2013 6:16:40 AM
More...
|
TNI BioTech Acquires the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists for the Treatment of Inflammatory and Ulcerative Diseases of the Bowel
1/8/2013 10:25:16 AM
More...
|
TNI BioTech to Present at 6th Annual OneMedForum San Francisco 2013
1/3/2013 8:09:28 AM
More...
|
Umbrella Research Initiates Coverage on TNI BioTech
12/27/2012 1:14:25 PM
More...
|
TNI BioTech Signs Exclusive Distributor Agreement for Federal Republic of Nigeria With G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
11/15/2012 10:33:27 AM
More...
|
|